Ex-Adviser Cops To Insider Trading Tied To $11B Pharma Deal

Law360, New York (September 30, 2013, 6:14 PM EDT) -- A former Florida financial adviser on Monday copped to insider trading charges tied to Gilead Sciences Inc.'s $11 billion acquisition of a New Jersey-based biotechnology company, admitting to a scheme that netted a trio of conspirators more than $700,000 from the pharmaceutical giant's deal.  

Kevin Dowd, 38, of Boca Raton, pled guilty to conspiracy to commit securities fraud in connection to insider information he shared with two co-conspirators, according to court documents. Dowd admitted to providing two people with information regarding Gilead's plans to purchase Pharmasset...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.